Pancreatic Cancer Research

ResearcherActive in the last 2 years

Masamori Shimabuku

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5024441207. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide… Co-author DOI 10.1136/jitc-2024-011426↗
  2. Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable … Co-author DOI 10.1136/jitc-2024-009765↗
  3. [Ⅳ. Dendritic Cell Immunotherapy as Pancreatic Cancer Treatment]. Co-author PMID 36281598↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshifumi Ohkusa · 2 shared papers, 2024–2025 · strength 0.38
  2. Shigetaka Shimodaira · 2 shared papers, 2024–2025 · strength 0.38
  3. Zensho Ito · 2 shared papers, 2024–2025 · strength 0.38
  4. Shigeo Koido · 2 shared papers, 2024–2025 · strength 0.38
  5. Masayuki Saruta · 2 shared papers, 2024–2025 · strength 0.38
  6. Haruo Sugiyama · 2 shared papers, 2024–2025 · strength 0.38
  7. Shin Kan · 1 shared paper, 2024 · strength 0.18
  8. Shintaro Tsukinaga · 1 shared paper, 2024 · strength 0.18
  9. Munehisa Kaneda · 1 shared paper, 2022 · strength 0.16
  10. Katsuiku Hirokawa · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.